首页> 外文期刊>Molecules >Simultaneous Determination of Four Tanshinones by UPLC-TQ/MS and Their Pharmacokinetic Application after Administration of Single Ethanol Extract of Danshen Combined with Water Extract in Normal and Adenine-Induced Chronic Renal Failure Rats
【24h】

Simultaneous Determination of Four Tanshinones by UPLC-TQ/MS and Their Pharmacokinetic Application after Administration of Single Ethanol Extract of Danshen Combined with Water Extract in Normal and Adenine-Induced Chronic Renal Failure Rats

机译:丹参单乙醇提取物联合水提取物联合正常和腺嘌呤诱发的慢性肾功能衰竭大鼠的UPLC-TQ / MS同时测定四种丹参酮及其药代动力学应用

获取原文
获取原文并翻译 | 示例
           

摘要

Salvia miltiorrhiza, one of the major traditional Chinese medicines, is commonly used and the main active ingredients-tanshinones-possess the ability to improve renal function. In this paper, the UPLC-TQ/MS method of simultaneously determining four tanshinones-tanshinone IIA, dihydrotanshinone I, tanshinone I, and cryptotanshinone-was established and applied to assess the pharmacokinetics in normal and chronic renal failure (CRF) rat plasma. The pharmacokinetics of tanshinones in rats were studied after separately intragastric administration of Salvia miltiorrhiza ethanol extract (SMEE) (0.65 g/kg), SMEE (0.65 g/kg) combined with Salvia miltiorrhiza water extract (SMWE) (1.55 g/kg). The results showed C-max and AUC(0-t) of tanshinone IIA, tanshinone I, cryptotanshinone reduced by 50%similar to 80% and CLz/F increased by 2 similar to 4 times (p < 0.05) in model group after administrated with SMEE. Nevertheless, after intragastric administration of a combination of SMWE and SMEE, the C-max and AUC(0-t) of four tanshinones were upregulated and CLz/F was downregulated, which undulated similarity from the model group to the normal group with compatibility of SMEE and SMWE. These results hinted that SMWE could improve the bioavailability of tanshinones in CRF rats, which provides scientific information for further exploration the mechanism of the combination of SMWE and SMEE and offers a reference for clinical administration of Salvia miltiorrhiza.
机译:丹参是主要的中药之一,是常用药,主要活性成分丹参酮具有改善肾功能的能力。本文建立了同时测定4种丹参酮-丹参酮IIA,二氢丹参酮I,丹参酮I和隐丹参酮的UPLC-TQ / MS方法,并将其用于评估正常和慢性肾衰竭(CRF)大鼠血浆中的药代动力学。对丹参酮在大鼠中分别进行胃内给药丹参乙醇提取物(SMEE)(0.65 g / kg),SMEE(0.65 g / kg)联合丹参水提取物(SMWE)(1.55 g / kg)进行药代动力学研究。结果显示,模型组给药后,丹参酮IIA,丹参酮I,隐丹参酮的C-max和AUC(0-t)降低了50%,与80%相似,CLz / F升高了2倍,接近4倍(p <0.05)与SMEE。然而,在胃内施用SMWE和SMEE的组合后,四种丹参酮的C-max和AUC(0-t)被上调,而CLz / F被下调,这在模型组和正常组之间具有相似性,并且具有SMEE和SMWE。这些结果提示SMWE可以改善丹参酮在CRF大鼠体内的生物利用度,为进一步探讨SMWE与SMEE的结合机理提供科学依据,并为丹参的临床管理提供参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号